This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Glaxo Group Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madrid, ES (2013)
- Tres Cantos, ES (2020)
Company Filing History:
1 out of 1,170 
1 out of 242 
Years Active: 2013-2020
Title: Lluis Ballell Pages: Innovator in Antituberculosis Research
Introduction
Lluis Ballell Pages is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antituberculosis agents. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
His latest patents include an antituberculosis agent that relates to the use of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione and its pharmaceutically acceptable salts. This invention also encompasses pharmaceutical formulations that utilize this compound. Another patent involves (Pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds, which are designed for therapeutic use, particularly in treating tuberculosis.
Career Highlights
Throughout his career, Lluis has worked with prominent companies such as GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovation.
Collaborations
He has collaborated with notable individuals in the field, including Julia Castro Pichel and Robert H Bates. These partnerships have likely enhanced his research and development efforts.
Conclusion
Lluis Ballell Pages stands out as an influential inventor in the pharmaceutical industry, particularly in the fight against tuberculosis. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile